2024-12-20 - Analysis Report
## Colgate-Palmolive Co (CL) Stock Review

**1. Performance Comparison & Divergence:**

Colgate-Palmolive Co (CL) is a consumer goods company that manufactures and sells oral hygiene, personal care, and household products worldwide.

The cumulative return of CL (42.34%) significantly lags behind the S&P 500 (VOO) cumulative return (114.28%) over the analyzed period.  The difference is -71.9%, placing it at the 9.2nd percentile of historical relative performance compared to the S&P 500. This indicates that CL's performance has underperformed the broader market considerably.  The provided alpha values consistently show underperformance compared to the market benchmark.

**2. Recent Price Movement:**

* **Closing Price:** $92.92
* **5-day Moving Average:** $93.10
* **20-day Moving Average:** $94.45
* **60-day Moving Average:** $96.12

The stock price is currently trading below its 5, 20, and 60-day moving averages, suggesting a downward trend.

**3. Technical Indicators and Expected Return:**

* **RSI (32.55):** Suggests the stock is currently in oversold territory.
* **PPO (-0.0995):** Indicates bearish momentum.
* **20-Day Relative Divergence Change (+6.5):**  Shows a recent short-term upward trend.
* **Expected Return (0.0%):**  The provided expected return of 0% suggests that, based on the available data, there is no anticipated outperformance relative to the S&P 500 over the long term (2+ years). This aligns with the historical underperformance.  The current price of $92.92, slightly below recent moving averages, doesn’t signal a significant immediate upward or downward trend. More data and analysis would be needed to determine whether this represents a buying opportunity due to being oversold or a continuation of the downward trend.

**4. Recent Earnings Analysis:**

The provided data shows a slight decline in revenue and EPS in the most recent quarter (2024-10-25) compared to the preceding quarters. While revenue remains relatively stable around $5 billion, EPS has decreased slightly.  There's no information provided on whether these figures met or missed analyst expectations.  It's worth noting the apparent duplication of the October 2024 data point.

| Date       | EPS | Revenue      | Revenue Change from Prior Quarter | EPS Change from Prior Quarter |
|------------|-----|---------------|---------------------------------|------------------------------|
| 2024-10-25 | 0.9 | $5.03 B      | -$0.03 B                         | -$0.01                         |
| 2024-07-26 | 0.89 | $5.06 B      | -$0.01 B                         | -$0.04                         |
| 2024-04-26 | 0.83 | $5.07 B      | -$0.12 B                         | -$0.03                         |
| 2023-10-27 | 0.86 | $4.92 B      | N/A                             | N/A                           |
| 2024-10-25 | 0.86 | $4.92 B      | N/A                             | N/A                           |

**5. Financial Information Analysis:**

* **Revenue and Profitability:** Revenue has been relatively stable, fluctuating slightly over the past year. Profit margins are consistently high (above 58%) but show a slight downward trend.
* **Capital and Profitability:** Equity and Return on Equity (ROE) figures show significant volatility, with some extremely high and negative values.  This indicates that the underlying accounting or financial position might require further investigation.  The extreme values for ROE in particular warrant more scrutiny into the methodology used in calculating these values.  The negative equity figure in 2023-09-30 and highly volatile ROE figures suggest potential issues which should be examined further.


**6. News and Recent Issues:**

No information regarding recent earnings news (within the last 2 days), market outlook, or analyst opinions is provided.  This is a critical gap in the analysis.

**7. Overall Analysis:**

Colgate-Palmolive's stock performance has significantly underperformed the S&P 500 over the analyzed period.  Technical indicators suggest the stock is currently oversold but lacks strong upward momentum.  While recent revenue has been relatively stable, EPS has shown a slight decline. The financial statements reveal volatile equity and ROE figures requiring further investigation. The lack of recent news and analyst opinions limits a comprehensive assessment.  Without additional information (particularly regarding earnings expectations and analyst sentiment), recommending a specific course of action is impossible. The high volatility in the reported financial information necessitates a deeper dive into the company's financial statements and disclosures before drawing definitive conclusions.

**8. Recommendations:**

Given the substantial underperformance relative to the market, the questionable financial data, and absence of current market information, a thorough investigation into the company’s fundamentals and recent announcements is crucial before making any investment decisions.  It is recommended to consult additional financial analysis, news sources, and company filings before taking any action with CL shares.  The high volatility of the equity and ROE suggests the need for a careful assessment of the company's financial health and prospects before investing.
